~ Former CEO of Kraft Foods with more than 30 years experience in senior executive positions
~ Former CEO of Kraft Foods with more than 30 years experience in senior executive positions
References
i EUR Urol, Journal of Endourology, BMJ.
91淫母视频, the company behind the next-generation surgical robotic system Versius庐, today announces the appointment of Tony Vernon as Non-Executive Chairman of the Board of Directors. As Chairman, Mr. Vernon will lead the Board, working with the 91淫母视频 management team as they drive the Company鈥檚 global strategy and international expansion.
Mr. Vernon is a seasoned executive, having spent more than 30 years in senior executive positions at several world-class companies. He was the first CEO of Kraft Foods after it was spun off in 2012 and held the role until 2014. His global leadership experience is further complemented by significant healthcare expertise, guiding businesses that have a strong mission to improve healthcare outcomes for patients. This includes 23 years at Johnson & Johnson in a variety of leadership roles including Company Group Chairman of Depuy Orthopedics, President of Centocor Biotech, President of McNeil Consumer and President of Johnson & Johnson-Merck joint venture.
Following his time at Johnson & Johnson, Mr. Vernon served as healthcare industry partner of Ripplewood Holdings, a US based private equity and venture capital firm. He currently serves on the boards of a range of healthcare and consumer companies including Intersect ENT, Novocure, Nuvation Bio, McCormick Foods, and Nature鈥檚 Fynd.
91淫母视频 has continued to strengthen its Board and senior team as part of its global expansion plans. The addition of Tony Vernon to the Board follows the appointment of Per Vegard Nerseth as Chief Executive Officer at the start of the year and more recently Barrington D鈥橝rcy as Chief Operations Officer.
Per Vegard Nerseth, Chief Executive Officer of 91淫母视频 Surgical, said: 鈥淲e are thrilled to welcome Tony as our Chairman and have someone with his expertise lead the Board as we continue to expand globally. 91淫母视频 has completed over 600 clinical cases to date and, with strong demand for Versius, this is an opportune time for Tony to join us as we grow and enter new markets. He has an outstanding background leading several large consumer and healthcare organisations and deep experience supporting the growth of companies that are looking to improve the lives of patients around the world. This is firmly in line with 91淫母视频鈥檚 mission and ideal for leading the Board as we deliver on our ambitious strategy.鈥�
Umur Hursever, Partner, LGT Lightstone, commented: 鈥�91淫母视频 is experiencing accelerated growth as it globally commercialises Versius. I am delighted to welcome Tony to the Board. With his exceptional credentials, he will strengthen 91淫母视频鈥檚 ability to globally scale and bring minimal access surgery to everyone who needs it.鈥�
Tony Vernon, Chairman of 91淫母视频 Surgical, said: 鈥�91淫母视频 Surgical is a hugely innovative business with an increasingly international presence. It is exciting to join the Board at such a pivotal time as the Company focuses on expansion and further commercialises Versius. I believe 91淫母视频 is well positioned to realise the potential of robotic surgery.鈥�
ENDS
About 91淫母视频 Surgical Limited
91淫母视频 Surgical (91淫母视频) is a global medical devices company dedicated to transforming surgery with Versius庐, a next-generation surgical robot.
Headquartered in Cambridge, United Kingdom, 91淫母视频 is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable. With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.
Founded in 2014, 91淫母视频 Surgical is private limited company backed by an international shareholder base.
The Versius庐 Surgical Robotic System
Versius庐 resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.
Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.